Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 701–800 of 1,001
Buckingham, B. A., Beck, R. W., Ruedy, K. J., Cheng, P., Kollman, C., WEINZIMER, S. A., DiMeglio, L. A., Bremer, A. A., Slover, R. H., & Cantwell, M. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0002 · Cited by 20
Zhou, J., Lv, X., Mu, Y., Wang, X., Li, J., Zhang, X., Wu, J., Bao, Y., & Jia, W. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0014 · Cited by 20
Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
Logel, S. N., Connor, E. L., Hsu, D., Fenske, R. J., Paloian, N. J., & Vivo, D. C. D. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51462 · Cited by 22
Zivojinovic, A. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105605 · Cited by 22
Can Technology Improve Adherence to Long-Term Therapies?
Reach, G. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300313 · Cited by 29
Insight into hypoglycemia in pediatric type 1 diabetes mellitus
Sawyer, K. E., Renukuntla, V. S., & Heptulla, R. A. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-19 · Cited by 23
Waite, M. A., Martin, C. E., Franklin, R. H., Duce, D. A., & Harrison, R. (2018) · JMIR Human Factors · doi:10.2196/humanfactors.9049 · Cited by 25
Anticoagulation protocol and early prosthetic valve thrombosis.
Talwar, S., Kapoor, C. K., Devagourou, V., & Kumar, A. S. (2004) · PubMed · Cited by 24
Sensor-Augmented Pump Therapy at 36 Months
Schmidt, S., & Nørgaard, K. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0148 · Cited by 19
Sørgård, B., Iversen, M. M., & Mårtensson, J. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14911 · Cited by 27
Hasan, R., Santiago, D. P., Churilla, J. R., Montes, B., Hossain, J., Mauras, N., & Darmaun, D. (2019) · Hormone Research in Paediatrics · doi:10.1159/000505328 · Cited by 23
Murata, T., Kuroda, A., Matsuhisa, M., Toyoda, M., Kimura, M., Hirota, Y., Kato, K., Sawaki, H., Tone, A., Kawashima, S., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820939204 · Cited by 19
Artificial Intelligence in Efficient Diabetes Care
Khodve, G., & Banerjee, S. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220905163940 · Cited by 20
MOSQUERA-LOPEZ, C. M., Roquemen-Echeverri, V., Tyler, N. S., Patton, S. R., Clements, M. A., Martin, C. K., Riddell, M. C., Gal, R. L., Gillingham, M. B., Wilson, L. M., et al. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad196 · Cited by 23
Bergenstal, R. M. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0005 · Cited by 20
Urakami, T., Terada, H., Tanabe, S., Mine, Y., Aoki, M., Aoki, R., Suzuki, J., & Morioka, I. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14303 · Cited by 22
O'Neal, D. N., Adhya, S., Jenkins, A., Ward, G., Welsh, J. B., & Voskanyan, G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700214 · Cited by 19
Scuffi, C. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2014.10.01.36 · Cited by 26
Klaprat, N. D., MacIntosh, A., & McGavock, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00042 · Cited by 22
Matsumoto, A., Kuwata, H., Kimura, S., Matsumoto, H., Ochi, K., Moro‐oka, Y., Watanabe, A., Yamada, H., Ishii, H., Miyazawa, T., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1026-x · Cited by 19
Myhre, J. N., Tejedor, M., Launonen, I. K., Fathi, A. E., & Godtliebsen, F. (2020) · Applied Sciences · doi:10.3390/app10186350 · Cited by 22
Minimally Invasive Enzyme Microprobes: An Alternative Approach for Continuous Glucose Monitoring
Moniz, A. R., Michelakis, K., Trzebinski, J., Sharma, S., Johnston, D. G., Oliver, N. S., & Cass, A. E. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600239 · Cited by 20
Maahs, D. M., Mayer‐Davis, E. J., Bishop, F. K., Wang, L. H.-C., Mangan, M., & McMurray, R. G. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0053 · Cited by 31
The clinical potential of low-level C-peptide secretion
Ludvigsson, J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1210513 · Cited by 20
Acute Metabolic Complications in Diabetes
Rewers, A. (2018) · Europe PMC (PubMed Central) · Cited by 38
Rizos, E. C., Markozannes, G., Charitakis, N., Filis, P., Stoimeni, A. E., Nørgaard, K., Ntzani, E. E., & Tsilidis, K. K. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0599 · Cited by 21
Cappon, G., Marturano, F., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818777524 · Cited by 18
Role of Continuous Glucose Monitoring in the Management of Diabetic Pregnancy
Hewapathirana, N. M., O'Sullivan, E., & Murphy, H. R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0337-9 · Cited by 20
Effect of Automated Bio-Behavioral Feedback on the Control of Type 1 Diabetes
Kovatchev, B. P., Mendosa, P., Anderson, S. M., Hawley, J. S., Ritterband, L. M., & Gonder-Frederick, L. A. (2011) · Diabetes Care · doi:10.2337/dc10-1366 · Cited by 19
Bringing closed-loop home: recent advances in closed-loop insulin delivery
Thabit, H., & Hovorka, R. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000048 · Cited by 20
Cichosz, S. L., Jensen, M. H., & Hejlesen, O. K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211069177 · Cited by 20
Andellini, M., Haleem, M. S., Angelini, M., Ritrovato, M., Schiaffini, R., Iadanza, E., & Pecchia, L. (2023) · Health and Technology · doi:10.1007/s12553-022-00719-x · Cited by 19
González‐Vidal, T., Rivas‐Otero, D., Agüeria‐Cabal, P., Ramos‐Ruiz, G., Delgado, E., & Torre, E. L. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0460 · Cited by 21
Kalita, D., Sharma, H., & Mirza, K. B. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3396880 · Cited by 21
Lever, C. S., Williman, J. A., Boucsein, A., Watson, A. S., Sampson, R. S., Sergel‐Stringer, O. T., Keesing, C., Chepulis, L. M., Wheeler, B. J., de Bock, M. I., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15348 · Cited by 20
Feasibility of Continuous Glucose Monitoring in Critically Ill Emergency Department Patients
Lee, J. H., Kim, K., Jo, Y. H., Rhee, J. E., Lee, J. C., Kim, K. S., Kwon, W. Y., Suh, G. J., Kim, H. C., Yoon, H. I., et al. (2011) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2011.06.037 · Cited by 19
Facchinetti, A., Sparacino, G., & Cobelli, C. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700522 · Cited by 20
Feasibility of 10-Day Use of a Continuous Glucose-Monitoring System in Adults With Type 1 Diabetes
Garg, S. K., Voelmle, M. K., & Gottlieb, P. A. (2008) · Diabetes Care · doi:10.2337/dc08-1745 · Cited by 18
A Model of Self-Monitoring Blood Glucose Measurement Error
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817698498 · Cited by 21
Early Racial/Ethnic Disparities in Continuous Glucose Monitor Use in Pediatric Type 1 Diabetes
Lai, C. W., Lipman, T. H., Willi, S. M., & Hawkes, C. P. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0120 · Cited by 18
Urakami, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030781 · Cited by 19
Mezquita‐Raya, P., Reyes‐García, R., Moreno, Ó., Muñoz‐Torres, M., Merino-Torres, J. F., Martínez, J. J. G., Jódar-Gimeno, E., Martín, J. E. S., Gargallo-Fernández, M., Soto-González, A., et al. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.11.009 · Cited by 27
Breton, M. D., Hinzmann, R., Campos-Náñez, E., Riddle, S., Schoemaker, M., & Schmelzeisen-Redeker, G. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816680633 · Cited by 19
Skyler, J. S. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0140 · Cited by 18
Cryer, P. E., & Arbeláez, A. M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch35 · Cited by 26
Maida, E., Caruso, P., Bonavita, S., Abbadessa, G., Miele, G., Longo, M., Scappaticcio, L., Ruocco, E., Trojsi, F., Esposito, K., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124240 · Cited by 15
Bally, L., Thabit, H., Tauschmann, M., Allen, J. M., Hartnell, S., Wilinska, M. E., Exall, J., Huegel, V., Sibayan, J., Borgman, S. K., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016738 · Cited by 17
Stanley, J. R., Clarke, A. B. M., Shulman, R. M., & Mahmud, F. H. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0388 · Cited by 18
Forecasting glucose values for patients with type 1 diabetes using heart rate data
Giancotti, R., Bosoni, P., Vizza, P., Tradigo, G., Gnasso, A., Guzzi, P. H., Bellazzi, R., Irace, C., & Veltri, P. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108438 · Cited by 18
Successes and Disappointments with Clinical Islet Transplantation
Cravedi, P., van der Meer, I. M., Cattaneo, S. G. D. A., Ruggenenti, P. L., & Remuzzi, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_33 · Cited by 20
Gómez, A. M., Grizales, A. M., Veloza, A., Sánchez, A. M., Múñoz, Ó., & Rondón, M. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.04.001 · Cited by 17
Continuous Subcutaneous Insulin Infusion—An Historical Perspective
Skyler, J. S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0068 · Cited by 19
Hypoglycemia - Causes and Occurrences
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/864 · Cited by 17
“…two groups, one using CGM and the other using self-glucose monitoring it was found that there was a significant improvement in hemoglobin A1C in patients using CGM as compared to patients using self-monitored finger stick glucose measurements after a 26 week trial (Tamborlane et al., 2008).”
MethodHoogeveen, I. J., Peeks, F., de Boer, F., Lubout, C. M. A., de Koning, T. J., Boekhorst, S. T., Zandvoort, R., Burghard, R., van Spronsen, F. J., & Derks, T. G. J. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0167-2 · Cited by 20
Deeb, A., Yousef, H., Qahtani, N. A., Artan, I., Suliman, S., Tomy, M., Abdulrahman, L., Suwaidi, H. A., Attia, S., & Nagelkerke, N. J. D. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0351-9 · Cited by 19
Styles, S. E., Gray, A. R., de Bock, M. I., Wiltshire, E. J., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., & Wheeler, B. J. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0378-z · Cited by 25
Ritholz, M. D., Henn, O., Atakov-Castillo, A., Wolpert, H. A., Edwards, S., Fisher, L., & Toschi, E. (2019) · JMIR Diabetes · doi:10.2196/14032 · Cited by 20
Nagel, K. E., Dearth‐Wesley, T., Herman, A. N., Smith, H. G., Gandica, R., Golden, L., Weil, H., & Whitaker, R. C. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13000 · Cited by 19
Health-System-Based Interventions to Improve Care in Pediatric and Adolescent Type 1 Diabetes
Corathers, S. D., Schoettker, P. J., Clements, M. A., List, B. A., Mullen, D. M., OHMER, A. L., Shah, A. C., & Lee, J. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0664-8 · Cited by 17
The Use of Continuous Glucose Monitoring in Patients with Type 2 Diabetes
Meade, L. T. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0086 · Cited by 19
Detection of Electrical Activity of Pancreatic Beta-cells Using Micro-electrode Arrays
Bornat, Y., Raoux, M., Boutaïb, Y., Morin, F. O., Charpentier, G., Lang, J., & Renaud, S. (2010) · IEEE International Workshop on Electronic Design, Test and Applications (DELTA) · doi:10.1109/delta.2010.60 · Cited by 17
Impact of new technologies on diabetes care
Giani, E., Scaramuzza, A. E., & Zuccotti, G. V. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.999 · Cited by 24
Diabetes Technology: Monitoring, Analytics, and Optimal Control
Kovatchev, B. P. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034389 · Cited by 17
Continuous Glucose Monitoring and Type 1 Diabetes
(2009) · New England Journal of Medicine · doi:10.1056/nejmc082243 · Cited by 17
Polsky, S., GIORDANO, D. A., Voelmle, M. K., Garcetti, R., & Garg, S. K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1159910 · Cited by 16
Choe, J., Won, S., Choe, Y., Park, S. H., Lee, Y. J., Lee, J. E., Lee, Y. A., Lim, H. H., Yoo, J. H., Lee, S. Y., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0274 · Cited by 19
Yu, Y., & McDonald, D. W. (2023) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3610097 · Cited by 19
Automated Insulin Delivery: A Milestone on the Road to Insulin Independence in Type 1 Diabetes
Limbert, C., Kowalski, A. J., & Danne, T. (2024) · Diabetes Care · doi:10.2337/dci24-0007 · Cited by 19
Facchinetti, A., Favero, S. D., Sparacino, G., & Cobelli, C. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6091226 · Cited by 16
Sharifi, A., Varsavsky, A., Ulloa, J., Horsburgh, J. C., McAuley, S. A., Krishnamurthy, B., Jenkins, A. J., Colman, P. G., Ward, G. M., MacIsaac, R. J., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815612096 · Cited by 19
Murphy, H. R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01145.x · Cited by 18
Barnard, K. D., Bromba, M., de Lange-Ranzijn, M., Halbron, M., Levy, B. L., Lévy, M., Lippmann-Grob, B., Walshe, K., & Ziegler, R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814567893 · Cited by 17
Juvenile Diabetes Research Foundation: Mission, Strategy, and Priorities
Insel, R. A., Deecher, D. C., & Brewer, J. M. (2011) · Diabetes · doi:10.2337/db11-1398 · Cited by 18
Boehm, B. O., Dreyer, M., Fritsche, A., Füchtenbusch, M., Gölz, S., & Martin, S. (2012) · Diabetologie und Stoffwechsel · doi:10.1055/s-0032-1325579 · Cited by 17
Design Considerations for Artificial Pancreas Pivotal Studies
Russell, S. J., & Beck, R. W. (2015) · Diabetes Care · doi:10.2337/dc15-2449 · Cited by 18
Galderisi, A., Tremblay, E. S., & Cengiz, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0944-6 · Cited by 20
Guilmin‐Crépon, S., Carel, J., Schroedt, J., Sulmont, V., Salmon-Musial, A. S., Tallec, C. L., Coutant, R., Dalla‐Vale, F., Stuckens, C., Bony-Trifunovic, H., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12820 · Cited by 18
Paret, M., Barash, G., & Rachmiel, M. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01446-y · Cited by 19
Integration of Islet/Beta-Cell Transplants with Host Tissue Using Biomaterial Platforms
Clough, D., King, J. L., Li, F., & Shea, L. D. (2020) · Endocrinology · doi:10.1210/endocr/bqaa156 · Cited by 18
Sun, K., Liu, S., Liu, J., Ding, Z., Jiang, Y., Zhang, J., Chen, H., Yu, J., Wu, C., & Chiu, D. T. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04223 · Cited by 17
Tanenbaum, M. L., Ngo, J., Hanes, S. J., Basina, M., Buckingham, B. A., Hessler, D., Maahs, D. M., Mulvaney, S. A., & Hood, K. K. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0198 · Cited by 19
Diabetes Technology Experiences Among Latinx and Non-Latinx Youth with Type 1 Diabetes
Tsai, D., Garcia, J. F., Fogel, J. L., Wee, C. P., Reid, M. W., & Raymond, J. K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211029260 · Cited by 18
Wiseman, A. C. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2009.04.001 · Cited by 16
Monitoring Glycemia in Diabetes
Healy, S. J., & Dungan, K. M. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.017 · Cited by 22
FRADKIN, J. E., Cowie, C. C., Hanlon, M. C., & Rodgers, G. P. (2013) · Diabetes · doi:10.2337/db13-1108 · Cited by 17
Responsivity to Problem-Solving Skills Training in Mothers of Children With Cancer
Dolgin, M. J., Devine, K. A., Tzur-Bitan, D., Askins, M. A., Fairclough, D. L., Katz, E. R., Noll, R. B., Phipps, S., & Sahler, O. J. Z. (2020) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsaa117 · Cited by 18
Hochfellner, D. A., Simic, A., Taucher, M. T., Sailer, L. S., Kopanz, J., Pöttler, T., & Mader, J. K. (2022) · Biosensors · doi:10.3390/bios12020106 · Cited by 15
Soare, A., Khazrai, Y. M., Fontana, L., Del Toro, R., Lazzaro, M. C., Di Rosa, C., Buldo, A., Fioriti, E., Maddaloni, E., Angeletti, S., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.023 · Cited by 15
New advances in insulin products
Rajpoot, K., Tekade, M., Sharma, M. C., Molugulu, N., & Tekade, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814455-8.00014-1 · Cited by 21
Twigg, S. M., Lim, S. K., Yoo, S.-H., Chen, L., Bao, Y., Kong, A. P. S., Yeoh, E. C. K., Chan, S. P., Robles, J., Mohan, V., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231176533 · Cited by 17
Tremblay, E. S., Bernique, A. S., Garvey, K., & Astley, C. M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231183985 · Cited by 16
Toschi, E., O'Neal, D. N., Munshi, M. N., & Jenkins, A. J. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241247568 · Cited by 16
Muscle regeneration and muscle stem cells in metabolic disease
Chung, J. D., Porrello, E. R., & Lynch, G. S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.041 · Cited by 16
Głowińska‐Olszewska, B., Tobiaszewska, M., Łuczyński, W., & Bossowski, A. T. (2013) · Advances in Medical Sciences · doi:10.2478/ams-2013-0024 · Cited by 16
Locke, A. K., Cummins, B. M., & Coté, G. L. (2016) · ACS Sensors · doi:10.1021/acssensors.5b00304 · Cited by 15
Gómez, A. M., Alfonso‐Cristancho, R., Orozco, J. J., Lynch, P. M., Prieto, D., Saunders, R., Roze, S., & Valencia, J. E. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.05.011 · Cited by 19
Gómez, A. M., Alfonso‐Cristancho, R., Orozco, J. J., Lynch, P. M., Prieto, D., Saunders, R., Roze, S., & Valencia, J. E. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.10.009 · Cited by 16
Type 1 Diabetes: Disease Stratification
Insel, R. A., Dutta, S., & Hedrick, J. A. (2017) · Biomedicine Hub · doi:10.1159/000481131 · Cited by 18
Diabetes Management Experience and the State of Hypoglycemia: National Online Survey Study
Zahed, K., Sasangohar, F., Mehta, R. K., Erraguntla, M., & Qaraqe, K. A. (2020) · JMIR Diabetes · doi:10.2196/17890 · Cited by 16
“This bolsters the argument in support of continuous monitoring technologies [61,62], since reliance on users’memory to sustain usage has proven to be challenging not only for diabetes but also for other chronic diseases [63,64].”
Functional data analysis and prediction tools for continuous glucose-monitoring studies
Gecili, E., Huang, R., Khoury, J. C., King, E. C., Altaye, M., Bowers, K. A., & Szczesniak, R. D. (2020) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.545 · Cited by 19
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.